BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32533098)

  • 1. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Lin CC; Yao CY; Hsu YC; Hou HA; Yuan CT; Li YH; Kao CJ; Chuang PH; Chiu YC; Chen Y; Chou WC; Tien HF
    Oncogene; 2020 Jul; 39(28):5112-5123. PubMed ID: 32533098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 is required for the quiescence of primitive hematopoietic cells.
    Nie Y; Han YC; Zou YR
    J Exp Med; 2008 Apr; 205(4):777-83. PubMed ID: 18378795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in
    Lin CC; Hsu YC; Li YH; Kuo YY; Hou HA; Lan KH; Chen TC; Tzeng YS; Kuo YY; Kao CJ; Chuang PH; Tseng MH; Chiu YC; Chou WC; Tien HF
    Haematologica; 2017 Jun; 102(6):1044-1053. PubMed ID: 28341738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation.
    Saha N; Ropa J; Chen L; Hu H; Mysliwski M; Friedman A; Maillard I; Muntean AG
    Stem Cell Reports; 2019 May; 12(5):1069-1083. PubMed ID: 31031188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
    Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
    Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHL2 regulates hematopoietic stem cell functions under stress conditions.
    Hou Y; Wang X; Li L; Fan R; Chen J; Zhu T; Li W; Jiang Y; Mittal N; Wu W; Peace D; Qian Z
    Leukemia; 2015 Mar; 29(3):615-24. PubMed ID: 25179730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress.
    Zhang Y; Dépond M; He L; Foudi A; Kwarteng EO; Lauret E; Plo I; Desterke C; Dessen P; Fujii N; Opolon P; Herault O; Solary E; Vainchenker W; Joulin V; Louache F; Wittner M
    Sci Rep; 2016 Nov; 6():37827. PubMed ID: 27886253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise Review: CXCR4/CXCL12 Signaling in Immature Hematopoiesis--Lessons From Pharmacological and Genetic Models.
    Karpova D; Bonig H
    Stem Cells; 2015 Aug; 33(8):2391-9. PubMed ID: 25966814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dock2 participates in bone marrow lympho-hematopoiesis.
    Kikuchi T; Kubonishi S; Shibakura M; Namba N; Matsui T; Fukui Y; Tanimoto M; Katayama Y
    Biochem Biophys Res Commun; 2008 Feb; 367(1):90-6. PubMed ID: 18157938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
    Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
    Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenvironment.
    Georgiou KR; Scherer MA; King TJ; Foster BK; Xian CJ
    Int J Exp Pathol; 2012 Apr; 93(2):104-14. PubMed ID: 22220905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin Enhances Quiescence Exit of Murine Hematopoietic Stem Cells and Hematopoietic Recovery Through mTORC1 Potentiation.
    Masamoto Y; Arai S; Sato T; Kubota N; Takamoto I; Kadowaki T; Kurokawa M
    Stem Cells; 2017 Jul; 35(7):1835-1848. PubMed ID: 28480607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.
    Lawson H; van de Lagemaat LN; Barile M; Tavosanis A; Durko J; Villacreces A; Bellani A; Mapperley C; Georges E; Martins-Costa C; Sepulveda C; Allen L; Campos J; Campbell KJ; O'Carroll D; Göttgens B; Cory S; Rodrigues NP; Guitart AV; Kranc KR
    Stem Cell Reports; 2021 Nov; 16(11):2784-2797. PubMed ID: 34715054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation.
    Singh P; Mohammad KS; Pelus LM
    Stem Cells; 2020 Jul; 38(7):849-859. PubMed ID: 32159901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
    Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
    Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCCTC-binding factor is essential to the maintenance and quiescence of hematopoietic stem cells in mice.
    Kim TG; Kim S; Jung S; Kim M; Yang B; Lee MG; Kim HP
    Exp Mol Med; 2017 Aug; 49(8):e371. PubMed ID: 28857086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors.
    Khurana S; Melacarne A; Yadak R; Schouteden S; Notelaers T; Pistoni M; Maes C; Verfaillie CM
    Stem Cells; 2014 Nov; 32(11):3012-22. PubMed ID: 25069965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
    Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
    Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
    Zhao C; Du F; Zhao Y; Wang S; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.